Delving into the Latest Updates on Yangyinshugan Granules with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Endocrinology and Metabolic DiseaseUrogenital Diseases

Active Indication

Ovarian Insufficiency

Inactive Indication-

Originator Organization

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Active Organization

Guangzhou General Pharmaceutical Research Institute Co. Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

Primary Objective: To preliminarily evaluate the efficacy and safety of Yangyin Shugan Granules in treating early-onset ovarian insufficiency (kidney deficiency and liver stagnation syndrome). Secondary Objective: To explore the optimal effective dose of Yangyin Shugan Granules in treating early-onset ovarian insufficiency (kidney deficiency and liver stagnation syndrome), providing a basis for phase III clinical trials.

Start Date22 May 2026

Sponsor / Collaborator

Guangzhou General Pharmaceutical Research Institute Co. Ltd.

ChiCTR-IOR-16007694

/ SuspendedNot Applicable

The research on menopause syndrome--menopause syndrom Nourishing kidney and regulating liver on early stage of ovary function declining during menopause transition period :randomize controlled study

Start Date01 Jul 2015

Sponsor / Collaborator

Guangdong Hospital of Traditional Chinese Medicine

100 Clinical Results associated with Yangyinshugan Granules

Login to view more data

100 Translational Medicine associated with Yangyinshugan Granules

Login to view more data

100 Patents (Medical) associated with Yangyinshugan Granules

Login to view more data

100 Deals associated with Yangyinshugan Granules

Login to view more data